You have 9 free searches left this month | for more free features.

axitinib

Showing 1 - 25 of 83

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Tampa (Ipilimumab, Axitinib)

Recruiting
  • Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Jun 21, 2022

Renal Cell Cancer Trial (Axitinib, Pembrolizumab)

Withdrawn
  • Renal Cell Cancer
  • (no location specified)
Jul 29, 2022

Recurrent ACC, metastaticACC, Unreaectable ACC Trial in Seoul (Axitinib, Observation)

Completed
  • Recurrent ACC, metastaticACC, Unreaectable ACC
  • Axitinib
  • Observation
  • Seoul, Korea, Republic of
    Department of Internal Medicine, Seoul National University Hospi
Mar 26, 2022

Cervical Cancer Trial in Hong Kong (Avelumab, Axitinib)

Recruiting
  • Cervical Cancer
  • Hong Kong, Hong Kong
    The University of Hong Kong
Feb 23, 2022

Hepatocellular Carcinoma Trial in Dallas (Axitinib, Avelumab, Bavituximab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Axitinib
  • +2 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Jun 27, 2022

Mucosal Melanoma Trial in New York (Nivolumab and/or Ipilimumab, Stereotactic Body Radiation Therapy (SBRT), axitinib)

Recruiting
  • Mucosal Melanoma
  • Nivolumab and/or Ipilimumab
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 14, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Axitinib
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Kidney Cancer Trial in Houston (Axitinib)

Active, not recruiting
  • Kidney Cancer
  • Axitinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 1, 2022

Clear Cell Renal Cell Carcinoma, First-line Treatment Trial in Shanghai (AK104, axitinib)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • First-line Treatment
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 16, 2022

Solitary Fibrous Tumor Trial in Milan (Axitinib)

Completed
  • Solitary Fibrous Tumor
  • Axitinib
  • Milan, MI, Italy
    Fondazione IRCCS Istituto Naazionale dei Tumori
Sep 22, 2021

Neurofibromatosis Type 2, Vestibular Schwannomas Trial in New York (Axitinib)

Completed
  • Neurofibromatosis Type 2
  • Vestibular Schwannomas
  • Axitinib
  • New York, New York
    NYU Langone Medical Center
Nov 24, 2021

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Dec 2, 2021

Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) Trial in Iowa City (Selenomethionine (SLM), Axitinib)

Recruiting
  • Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
  • Selenomethionine (SLM)
  • Axitinib
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 13, 2021

Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 17, 2022

Axitinib Dose Reduction and Interruption for Adverse Event

Active, not recruiting
  • Renal Cell Carcinoma
  • Axitinib
  • +2 more
  • New York, New York
    Pfizer
Jun 9, 2021

Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic Trial in Iowa City (Selenomethionine (SLM),

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma Metastatic
  • Selenomethionine (SLM)
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
May 9, 2022

And Use Of Avelumab In Combination With Axitinib For Treatment

Recruiting
  • Advanced Renal Cell Carcinoma
  • Sandwich, Kent, United Kingdom
    Pfizer Ltd
May 23, 2022

Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas Trial in Miami (Axitinib, Pembrolizumab)

Active, not recruiting
  • Alveolar Soft Part Sarcoma
  • Soft Tissue Sarcomas
  • Miami, Florida
    University of Miami
Oct 29, 2021

Metastatic Renal Cell Cancer Trial in United States (Axitinib)

Active, not recruiting
  • Metastatic Renal Cell Cancer
  • Axitinib
  • Duarte, California
  • +3 more
Jun 1, 2022

Renal Cell Carcinoma Trial in United States (Nivolumab, Axitinib)

Recruiting
  • Renal Cell Carcinoma
  • Baltimore, Maryland
  • +3 more
Nov 16, 2021

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Pembrolizumab, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Jul 30, 2021

Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Sintilimab, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Jul 1, 2021

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant

Not yet recruiting
  • Melanoma Stage IV
  • Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
  • +2 more
  • (no location specified)
Sep 27, 2021

Squamous Cell Carcinoma of the Head and Neck Trial in Ann Arbor (Axitinib)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Axitinib
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Apr 9, 2021